Table 5– Treatment-emergent adverse events during the study (safety set)
Adverse eventsPlaceboSelexipag
Subjects1033
Patients with ≥1 adverse event1031
Adverse events >10% on selexipag
 Headache222
 Jaw pain12
 Pain in an extremity10
 Nausea9
 Nasopharyngitis28
 Diarrhoea16
 Flushing6
 Dizziness5
 Cough4
 Myalgia4
  • Data are presented as n.